vs
ICU MEDICAL INC（ICUI）与MACOM Technology Solutions Holdings, Inc.（MTSI）财务数据对比。点击上方公司名可切换其他公司
ICU MEDICAL INC的季度营收约是MACOM Technology Solutions Holdings, Inc.的2.0倍（$540.7M vs $271.6M），MACOM Technology Solutions Holdings, Inc.净利率更高（18.0% vs -2.9%，领先20.9%），MACOM Technology Solutions Holdings, Inc.同比增速更快（24.5% vs -14.1%），ICU MEDICAL INC自由现金流更多（$36.0M vs $30.0M），过去两年MACOM Technology Solutions Holdings, Inc.的营收复合增速更高（22.4% vs -2.3%）
ICU医疗是总部位于美国加利福尼亚州圣克莱门特的医疗科技企业，专注于研发预防血流感染、保护医护人员免受传染病或危险药物侵害的医疗产品，产品线覆盖静脉治疗用品、输液泵、无针血管通路设备、定制输液套装、危险药物密闭处理系统、传感导管以及无针封闭式血液采样系统等。
MACOM是美国知名的射频、微波及毫米波半导体器件与组件研发生产商，总部位于马萨诸塞州洛厄尔，2005年曾是当地规模最大的私营雇主。公司已通过ISO9001国际质量体系认证及ISO14001环境管理体系认证，在北美、欧洲、亚洲及澳大利亚均设有设计中心与销售办事处。
ICUI vs MTSI — 直观对比
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $540.7M | $271.6M |
| 净利润 | $-15.7M | $48.8M |
| 毛利率 | 37.5% | 55.9% |
| 营业利润率 | 1.0% | 15.9% |
| 净利率 | -2.9% | 18.0% |
| 营收同比 | -14.1% | 24.5% |
| 净利润同比 | 34.0% | 129.1% |
| 每股收益（稀释后） | $-0.63 | $0.64 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q1 26 | — | $271.6M | ||
| Q4 25 | $540.7M | $261.2M | ||
| Q3 25 | $537.0M | $252.1M | ||
| Q2 25 | $548.9M | $235.9M | ||
| Q1 25 | $604.7M | $218.1M | ||
| Q4 24 | $629.8M | — | ||
| Q3 24 | $589.1M | $200.7M | ||
| Q2 24 | $596.5M | $190.5M |
| Q1 26 | — | $48.8M | ||
| Q4 25 | $-15.7M | $45.1M | ||
| Q3 25 | $-3.4M | $36.5M | ||
| Q2 25 | $35.3M | $31.7M | ||
| Q1 25 | $-15.5M | $-167.5M | ||
| Q4 24 | $-23.8M | — | ||
| Q3 24 | $-33.0M | $29.4M | ||
| Q2 24 | $-21.4M | $19.9M |
| Q1 26 | — | 55.9% | ||
| Q4 25 | 37.5% | 54.5% | ||
| Q3 25 | 37.4% | 55.3% | ||
| Q2 25 | 37.9% | 55.2% | ||
| Q1 25 | 34.7% | 53.7% | ||
| Q4 24 | 36.1% | — | ||
| Q3 24 | 34.8% | 54.7% | ||
| Q2 24 | 34.8% | 53.2% |
| Q1 26 | — | 15.9% | ||
| Q4 25 | 1.0% | 15.2% | ||
| Q3 25 | 2.6% | 14.9% | ||
| Q2 25 | 1.9% | 14.8% | ||
| Q1 25 | 2.1% | 8.0% | ||
| Q4 24 | 6.0% | — | ||
| Q3 24 | 1.4% | 13.7% | ||
| Q2 24 | 1.3% | 10.4% |
| Q1 26 | — | 18.0% | ||
| Q4 25 | -2.9% | 17.3% | ||
| Q3 25 | -0.6% | 14.5% | ||
| Q2 25 | 6.4% | 13.4% | ||
| Q1 25 | -2.6% | -76.8% | ||
| Q4 24 | -3.8% | — | ||
| Q3 24 | -5.6% | 14.7% | ||
| Q2 24 | -3.6% | 10.5% |
| Q1 26 | — | $0.64 | ||
| Q4 25 | $-0.63 | $0.67 | ||
| Q3 25 | $-0.14 | $0.48 | ||
| Q2 25 | $1.43 | $0.42 | ||
| Q1 25 | $-0.63 | $-2.30 | ||
| Q4 24 | $-0.97 | — | ||
| Q3 24 | $-1.35 | $0.40 | ||
| Q2 24 | $-0.88 | $0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $768.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $2.1B | $1.4B |
| 总资产 | $4.1B | $2.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q1 26 | — | $768.5M | ||
| Q4 25 | — | $786.0M | ||
| Q3 25 | — | $735.2M | ||
| Q2 25 | — | $681.5M | ||
| Q1 25 | — | $656.5M | ||
| Q4 24 | $308.6M | — | ||
| Q3 24 | $312.5M | $581.9M | ||
| Q2 24 | $302.6M | $521.5M |
| Q1 26 | — | $1.4B | ||
| Q4 25 | $2.1B | $1.3B | ||
| Q3 25 | $2.1B | $1.3B | ||
| Q2 25 | $2.1B | $1.2B | ||
| Q1 25 | $2.0B | $1.2B | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $2.0B | $1.1B | ||
| Q2 24 | $2.0B | $1.1B |
| Q1 26 | — | $2.1B | ||
| Q4 25 | $4.1B | $2.1B | ||
| Q3 25 | $4.1B | $2.0B | ||
| Q2 25 | $4.1B | $1.9B | ||
| Q1 25 | $4.2B | $1.8B | ||
| Q4 24 | $4.2B | — | ||
| Q3 24 | $4.3B | $1.8B | ||
| Q2 24 | $4.3B | $1.7B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $60.6M | $42.9M |
| 自由现金流经营现金流 - 资本支出 | $36.0M | $30.0M |
| 自由现金流率自由现金流/营收 | 6.6% | 11.0% |
| 资本支出强度资本支出/营收 | 4.6% | 4.8% |
| 现金转化率经营现金流/净利润 | — | 0.88× |
| 过去12个月自由现金流最近4个季度 | $91.8M | $161.5M |
8季度趋势，按日历期对齐
| Q1 26 | — | $42.9M | ||
| Q4 25 | $60.6M | $69.6M | ||
| Q3 25 | $56.7M | $60.4M | ||
| Q2 25 | $11.2M | $38.7M | ||
| Q1 25 | $51.3M | $66.7M | ||
| Q4 24 | $40.2M | — | ||
| Q3 24 | $36.1M | $62.3M | ||
| Q2 24 | $82.0M | $49.0M |
| Q1 26 | — | $30.0M | ||
| Q4 25 | $36.0M | $49.4M | ||
| Q3 25 | $27.6M | $51.6M | ||
| Q2 25 | $-8.5M | $30.5M | ||
| Q1 25 | $36.7M | $61.3M | ||
| Q4 24 | $16.1M | — | ||
| Q3 24 | $16.2M | $57.1M | ||
| Q2 24 | $62.5M | $41.5M |
| Q1 26 | — | 11.0% | ||
| Q4 25 | 6.6% | 18.9% | ||
| Q3 25 | 5.1% | 20.5% | ||
| Q2 25 | -1.5% | 12.9% | ||
| Q1 25 | 6.1% | 28.1% | ||
| Q4 24 | 2.6% | — | ||
| Q3 24 | 2.7% | 28.5% | ||
| Q2 24 | 10.5% | 21.8% |
| Q1 26 | — | 4.8% | ||
| Q4 25 | 4.6% | 7.7% | ||
| Q3 25 | 5.4% | 3.5% | ||
| Q2 25 | 3.6% | 3.5% | ||
| Q1 25 | 2.4% | 2.4% | ||
| Q4 24 | 3.8% | — | ||
| Q3 24 | 3.4% | 2.6% | ||
| Q2 24 | 3.3% | 3.9% |
| Q1 26 | — | 0.88× | ||
| Q4 25 | — | 1.54× | ||
| Q3 25 | — | 1.65× | ||
| Q2 25 | 0.32× | 1.22× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.12× | ||
| Q2 24 | — | 2.46× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ICUI
| Infusion Consumables | $284.7M | 53% |
| Infusion Systems | $176.3M | 33% |
| Vital Care | $79.7M | 15% |
MTSI
| Industrial Defense | $117.7M | 43% |
| Data Center | $85.8M | 32% |
| Telecom | $68.1M | 25% |
